Search Results - "Khial, F"

Concomitant brain radiotherapy and high-dose ifosfamide in brain relapses of lung cancer by Quantin, X., Pujol, J.-L., Paris, A., Reme-Saumon, M., Khial, F., Godard, P., Michel, F.-B.

“…Patients and methods: Twenty patients with lung cancer and brain metastasis were prospectively included in this feasibility study (four small-cell and 16…”
Get full text

Multimodality treatment program in invasive thymic epithelial tumor by Jacot, William, Quantin, Xavier, Valette, Sarah, Khial, Farid, Pujol, Jean Louis

“…Little is known regarding malignant thymoma and thymic carcinoma optimal therapy, and a multimodality approach could therefore be proposed in an attempt to…”
Get full text

Combination chemotherapy without cisplatin in the treatment of advanced non-small cell lung cancer by Pujol, Jean-Louis, Quantin, Xavier, Choma, Didier, Jacot, William, Khial, Farid

“…Cisplatin-based combinations are standard regimens in the treatment of advanced non-small cell lung cancer. Survival improvement has been achieved using this…”
Get full text

Concomitant brain radiotherapy and vinorelbine–ifosfamide–cisplatin chemotherapy in brain metastases of non-small cell lung cancer by Quantin, Xavier, Khial, Farid, Reme-Saumon, Monique, Michel, François-Bernard, Pujol, Jean-Louis

“…Aim: To determine whether or not brain radiotherapy and concomitant three-drug chemotherapy is feasible and yields anti-tumour activity in patients with…”
Get full text

A phase I–II study of docetaxel (D) and gemcitabine (G) combination in patients (pts) with non-small cell lung cancer (NSCLC) by Quantin, X, Rebattu, P, Pujol, J, Morere, J, Azarian, M.R, Khial, F, Dumortier, A, Schuller-Lebeau, M.P

Get full text

225 Phase I–II study of high dose epidoxorubicin (EPI) plus cisplatin (DDP) in IIIb or IV non-small cell lung cancer (NSCLC): Searching the optimal DDP dosage by Quantin, X., Oliver, P., Rivière, A., Khial, F., Madelaine, J., Pujol, J.L.

Get full text

498 Concomitant brain radiotherapy and high-dose ifosfamide in brain relapses of lung cancer by Quantin, X., Pujol, J.L., Paris, A., Khial, F., Reme-Saumon, M., Dubois, J.B.

Get full text

Neoadjuvant etoposide, ifosfamide, and cisplatin followed by concomitant thoracic radiotherapy and continuous cisplatin infusion in stage IIIb non-small cell lung cancer by Pujol, J L, Lafontaine, T, Quantin, X, Reme-Saumon, M, Cupissol, D, Khial, F, Michel, F B

“…To determine the applicability and safety of an ifosfamide, cisplatin, and etoposide (VIP) regimen as a neoadjuvant chemotherapy to a concomitant thoracic…”
Get more information

Phase I-II study of high dose epirubicin plus cisplatin in unresectable non-small-cell lung cancer : Searching for the maximal tolerated dose by QUANTIN, X, RIVIERE, A, DAURES, J.-P, OLIVER, P, COMTE-BARDONNET, M, KHIAL, F, MARCILLAC, I, PUJOL, J.-L

“…The purpose of this study was to search for the maximal tolerated dose of cisplatin in the cisplatin plus high-dose epirubicin combination for patients with…”
Get full text

Which chemotherapy for diffuse forms of small-cell cancers? by Pujol, J L, Quantin, X, Carestia, L, Guyot, V, Khial, F

Get more information